Loading...
XNAS
INGN
Market cap176mUSD
Jul 09, Last price  
6.53USD
1D
0.62%
1Q
3.16%
Jan 2017
-90.28%
IPO
-57.18%
Name

Inogen Inc

Chart & Performance

D1W1MN
XNAS:INGN chart
P/E
—
P/S
0.51
EPS
—
Div Yield, %
—
Shrs. gr., 5y
4.34%
Rev. gr., 5y
2.48%
Revenues
349m
+3.86%
30,634,00048,576,00075,443,000112,537,000159,005,000202,829,000249,438,000358,111,000361,943,000308,487,000358,003,000377,241,000315,660,000335,705,000348,668,000
Net income
-23m
L-36.62%
-2,002,000564,00025,435,0006,826,00011,585,00020,519,00021,002,00051,845,00020,950,000-5,829,000-6,333,000-83,772,000-102,449,000-35,888,000-22,747,000
CFO
-11m
L
1,859,0004,004,00013,467,00015,697,00038,161,00031,034,00060,494,00059,977,00040,593,00037,013,00023,633,000-37,532,000-3,234,0005,914,000-11,216,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
URL
https://www.inogen.com/
IPO date
Feb 14, 2014
Employees
1,026
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT